SLC5A2 and type 2 diabetes mellitus: SGLT-2 (sodium-glucose cotransporter-2) inhibitors are the last class of antidiabetic drugs approved by FDA and EMA regulatory agencies, which could be used in any stage of T2DM, irrespective of comedications.